当期报告
诺瓦瓦克斯医药(NVAX)
$诺瓦瓦克斯医药(NVAX)$ 8-K Current report, items 1.01, 2.03, 3.02, and 9.01 Accession Number: 0001104659-25-084053 Act: 34 Size: 1 MB 网页链接
$诺瓦瓦克斯医药(NVAX)$ 8-K Current report, items 1.01, 2.03, 3.02, and 9.01 Accession Number: 0001104659-25-084053 Act: 34 Size: 1 MB 网页链接